From: SGEF is a potential prognostic and therapeutic target for lung adenocarcinoma
Factors | Univariate | Multivariate | ||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Gender | 0.666 (0.379–1.169) | 0.156 | 0.578 (0.321–1.042) | 0.069 |
Age | 1.019 (0.996–1.042) | 0.839 | 1.045 (1.010–1.081) | 0.011 |
Location | 0.993 (0.527–1.651) | 0.811 | 1.127 (0.587–2.164) | 0.718 |
SGEF expression | 1.846 (1.029–3.310) | 0.040 | 1.126 (0.631–2.382) | 0.547 |
Grade | 2.474 (1.351–4.532) | 0.003 | 2.337 (1.177–4.643) | 0.015 |
TNM stage | 1.603 (1.159–2.217) | 0.004 | 1.532 (1.052–2.202) | 0.026 |